- Home
- ETON
as 07-26-2024 4:00pm EST
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | DEER PARK |
| Market Cap: | 87.6M | IPO Year: | 2018 |
| Target Price: | $9.00 | AVG Volume (30 days): | 51.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.42 - $5.81 | Next Earning Date: | 08-08-2024 |
| Revenue: | $35,304,000 | Revenue Growth: | 35.69% |
| Revenue Growth (this year): | 21.09% | Revenue Growth (next year): | 22.32% |
Latest Eton Pharmaceuticals Inc. News
ETON Breaking Stock News: Dive into ETON Ticker-Specific Updates for Smart Investing
ACCESSWIRE
9 days ago
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
MT Newswires
11 days ago
Eton Pharmaceuticals Shares Surge After FDA Accepts ET-400 New Drug Application For Review
GlobeNewswire
11 days ago
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
Simply Wall St.
a month ago
Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Simply Wall St.
2 months ago
Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
Thomson Reuters StreetEvents
3 months ago
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
GlobeNewswire
3 months ago
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
Simply Wall St.
3 months ago
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even
Compare ETON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ETON Eton Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.